Exothera develops exoREADY, Viral Vector Production Platform boosting advanced therapy

Exothera S.A., a leading CDMO that specializes in the development and manufacture of viral vectors for vaccines and gene therapies, has developed and is continuing to improve the exoREADY platform for accelerated viral vector manufacture. This fully integrated platform will ensure faster, more cost-effective production of viral vector-based therapeutics (for gene therapy, vaccines, and oncolytic […]